Table 1.

L1CAM expression and clinicopathological parameters

	n	%	L1CAM negative	%	L1CAM positive	%	p-value/ tau
Total	468	100	353	75.4	115	24.6
Age ≤64 years	227	48.5	178	78.4	49	21.6	ns
Age > 64 years	241	51.5	175	72.6	66	27.4
Male	325	69.4	243	74.8	82	25.2	ns
Female	143	30.6	110	76.9	33	23.1
SCC	242	51.7	181	74.8	61	25.2	ns
ADCA	226	48.3	172	76.1	54	23.9
pT1	98	20.9	78	79.6	20	20.4	ns
pT2	256	54.7	195	76.2	61	23.8
pT3	69	14.7	50	72.5	19	27.5
pT4	45	9.6	30	66.7	15	33.3
pN0	244	52.1	186	76.2	58	23.8	ns
pN1	142	30.3	110	77.5	32	22.5
pN2	72	15.4	51	70.8	21	29.2
pN3	10	2.1	6	60	4	40
pM0	430	91.9	330	76.7	100	23.3	0.031/
pM1	38	8.1	23	60.5	15	39.5	0.1
G1	28	6	22	78.6	6	21.4	ns
G2	245	52.3	187	76.3	58	23.7
G3	195	41.7	144	73.8	51	26.2
Size < 3.7cm	241	51.5	189	78.4	52	21.6	ns
Size ≥ 3.7cm	227	48.5	164	72.2	63	27.8
No vessel infiltration	249	53.2	197	79.1	52	20.9	0.036/
Vessel infiltration	219	46.8	156	71.2	63	28.8	0.09

Neg. negative, pos. positive, ns not significant, tau correlation coefficient